Global Imatinib Drugs Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Imatinib Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Imatinib Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Capsules
  • 1.2.3 Tablets
• 1.3 Market by Application
  • 1.3.1 Global Imatinib Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospitals
  • 1.3.3 Drug Stores
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Imatinib Drugs Sales Estimates and Forecasts 2017-2028
• 2.2 Global Imatinib Drugs Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Imatinib Drugs Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Imatinib Drugs Sales by Region
  • 2.4.1 Global Imatinib Drugs Sales by Region (2017-2022)
  • 2.4.2 Global Sales Imatinib Drugs by Region (2023-2028)
• 2.5 Global Imatinib Drugs Revenue by Region
  • 2.5.1 Global Imatinib Drugs Revenue by Region (2017-2022)
  • 2.5.2 Global Imatinib Drugs Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Imatinib Drugs Sales by Manufacturers
  • 3.1.1 Global Top Imatinib Drugs Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Imatinib Drugs Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Imatinib Drugs in 2021
• 3.2 Global Imatinib Drugs Revenue by Manufacturers
  • 3.2.1 Global Imatinib Drugs Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Imatinib Drugs Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Imatinib Drugs Revenue in 2021
• 3.3 Global Imatinib Drugs Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Imatinib Drugs Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Imatinib Drugs Sales by Type
  • 4.1.1 Global Imatinib Drugs Historical Sales by Type (2017-2022)
  • 4.1.2 Global Imatinib Drugs Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Imatinib Drugs Sales Market Share by Type (2017-2028)
• 4.2 Global Imatinib Drugs Revenue by Type
  • 4.2.1 Global Imatinib Drugs Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Imatinib Drugs Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Imatinib Drugs Revenue Market Share by Type (2017-2028)
• 4.3 Global Imatinib Drugs Price by Type
  • 4.3.1 Global Imatinib Drugs Price by Type (2017-2022)
  • 4.3.2 Global Imatinib Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Imatinib Drugs Sales by Application
  • 5.1.1 Global Imatinib Drugs Historical Sales by Application (2017-2022)
  • 5.1.2 Global Imatinib Drugs Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Imatinib Drugs Sales Market Share by Application (2017-2028)
• 5.2 Global Imatinib Drugs Revenue by Application
  • 5.2.1 Global Imatinib Drugs Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Imatinib Drugs Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Imatinib Drugs Revenue Market Share by Application (2017-2028)
• 5.3 Global Imatinib Drugs Price by Application
  • 5.3.1 Global Imatinib Drugs Price by Application (2017-2022)
  • 5.3.2 Global Imatinib Drugs Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Imatinib Drugs Market Size by Type
  • 6.1.1 North America Imatinib Drugs Sales by Type (2017-2028)
  • 6.1.2 North America Imatinib Drugs Revenue by Type (2017-2028)
• 6.2 North America Imatinib Drugs Market Size by Application
  • 6.2.1 North America Imatinib Drugs Sales by Application (2017-2028)
  • 6.2.2 North America Imatinib Drugs Revenue by Application (2017-2028)
• 6.3 North America Imatinib Drugs Market Size by Country
  • 6.3.1 North America Imatinib Drugs Sales by Country (2017-2028)
  • 6.3.2 North America Imatinib Drugs Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Imatinib Drugs Market Size by Type
  • 7.1.1 Europe Imatinib Drugs Sales by Type (2017-2028)
  • 7.1.2 Europe Imatinib Drugs Revenue by Type (2017-2028)
• 7.2 Europe Imatinib Drugs Market Size by Application
  • 7.2.1 Europe Imatinib Drugs Sales by Application (2017-2028)
  • 7.2.2 Europe Imatinib Drugs Revenue by Application (2017-2028)
• 7.3 Europe Imatinib Drugs Market Size by Country
  • 7.3.1 Europe Imatinib Drugs Sales by Country (2017-2028)
  • 7.3.2 Europe Imatinib Drugs Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Imatinib Drugs Market Size by Type
  • 8.1.1 Asia Pacific Imatinib Drugs Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Imatinib Drugs Revenue by Type (2017-2028)
• 8.2 Asia Pacific Imatinib Drugs Market Size by Application
  • 8.2.1 Asia Pacific Imatinib Drugs Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Imatinib Drugs Revenue by Application (2017-2028)
• 8.3 Asia Pacific Imatinib Drugs Market Size by Region
  • 8.3.1 Asia Pacific Imatinib Drugs Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Imatinib Drugs Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Imatinib Drugs Market Size by Type
  • 9.1.1 Latin America Imatinib Drugs Sales by Type (2017-2028)
  • 9.1.2 Latin America Imatinib Drugs Revenue by Type (2017-2028)
• 9.2 Latin America Imatinib Drugs Market Size by Application
  • 9.2.1 Latin America Imatinib Drugs Sales by Application (2017-2028)
  • 9.2.2 Latin America Imatinib Drugs Revenue by Application (2017-2028)
• 9.3 Latin America Imatinib Drugs Market Size by Country
  • 9.3.1 Latin America Imatinib Drugs Sales by Country (2017-2028)
  • 9.3.2 Latin America Imatinib Drugs Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Imatinib Drugs Market Size by Type
  • 10.1.1 Middle East and Africa Imatinib Drugs Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Imatinib Drugs Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Imatinib Drugs Market Size by Application
  • 10.2.1 Middle East and Africa Imatinib Drugs Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Imatinib Drugs Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Imatinib Drugs Market Size by Country
  • 10.3.1 Middle East and Africa Imatinib Drugs Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Imatinib Drugs Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Apotex Inc.
  • 11.1.1 Apotex Inc. Corporation Information
  • 11.1.2 Apotex Inc. Overview
  • 11.1.3 Apotex Inc. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Apotex Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Apotex Inc. Recent Developments
• 11.2 Novartis
  • 11.2.1 Novartis Corporation Information
  • 11.2.2 Novartis Overview
  • 11.2.3 Novartis Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 Novartis Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Novartis Recent Developments
• 11.3 Sanofi S.A.
  • 11.3.1 Sanofi S.A. Corporation Information
  • 11.3.2 Sanofi S.A. Overview
  • 11.3.3 Sanofi S.A. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Sanofi S.A. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Sanofi S.A. Recent Developments
• 11.4 Cipla Inc.
  • 11.4.1 Cipla Inc. Corporation Information
  • 11.4.2 Cipla Inc. Overview
  • 11.4.3 Cipla Inc. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Cipla Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Cipla Inc. Recent Developments
• 11.5 Mylan Pharms Inc.
  • 11.5.1 Mylan Pharms Inc. Corporation Information
  • 11.5.2 Mylan Pharms Inc. Overview
  • 11.5.3 Mylan Pharms Inc. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Mylan Pharms Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Mylan Pharms Inc. Recent Developments
• 11.6 Glenmark Pharmaceuticals Ltd.
  • 11.6.1 Glenmark Pharmaceuticals Ltd. Corporation Information
  • 11.6.2 Glenmark Pharmaceuticals Ltd. Overview
  • 11.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Glenmark Pharmaceuticals Ltd. Recent Developments
• 11.7 Sun Pharmaceuticals
  • 11.7.1 Sun Pharmaceuticals Corporation Information
  • 11.7.2 Sun Pharmaceuticals Overview
  • 11.7.3 Sun Pharmaceuticals Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Sun Pharmaceuticals Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Sun Pharmaceuticals Recent Developments
• 11.8 Actavis Generics
  • 11.8.1 Actavis Generics Corporation Information
  • 11.8.2 Actavis Generics Overview
  • 11.8.3 Actavis Generics Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Actavis Generics Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Actavis Generics Recent Developments
• 11.9 Dr. Reddy's Laboratories
  • 11.9.1 Dr. Reddy's Laboratories Corporation Information
  • 11.9.2 Dr. Reddy's Laboratories Overview
  • 11.9.3 Dr. Reddy's Laboratories Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Dr. Reddy's Laboratories Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Dr. Reddy's Laboratories Recent Developments
• 11.10 Teva Pharmaceutical Industries Ltd.
  • 11.10.1 Teva Pharmaceutical Industries Ltd. Corporation Information
  • 11.10.2 Teva Pharmaceutical Industries Ltd. Overview
  • 11.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Imatinib Drugs Industry Chain Analysis
• 12.2 Imatinib Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Imatinib Drugs Production Mode & Process
• 12.4 Imatinib Drugs Sales and Marketing
  • 12.4.1 Imatinib Drugs Sales Channels
  • 12.4.2 Imatinib Drugs Distributors
• 12.5 Imatinib Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Imatinib Drugs Industry Trends
• 13.2 Imatinib Drugs Market Drivers
• 13.3 Imatinib Drugs Market Challenges
• 13.4 Imatinib Drugs Market Restraints

14 Key Findings in The Global Imatinib Drugs Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Imatinib Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Capsules
• Table 3. Major Manufacturers of Tablets
• Table 4. Global Imatinib Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 5. Global Imatinib Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 6. Global Imatinib Drugs Sales by Region (2017-2022) & (K MT)
• Table 7. Global Imatinib Drugs Sales Market Share by Region (2017-2022)
• Table 8. Global Imatinib Drugs Sales by Region (2023-2028) & (K MT)
• Table 9. Global Imatinib Drugs Sales Market Share by Region (2023-2028)
• Table 10. Global Imatinib Drugs Revenue by Region (2017-2022) & (US$ Million)
• Table 11. Global Imatinib Drugs Revenue Market Share by Region (2017-2022)
• Table 12. Global Imatinib Drugs Revenue by Region (2023-2028) & (US$ Million)
• Table 13. Global Imatinib Drugs Revenue Market Share by Region (2023-2028)
• Table 14. Global Imatinib Drugs Sales by Manufacturers (2017-2022) & (K MT)
• Table 15. Global Imatinib Drugs Sales Share by Manufacturers (2017-2022)
• Table 16. Global Imatinib Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 17. Global Imatinib Drugs Revenue Share by Manufacturers (2017-2022)
• Table 18. Imatinib Drugs Price by Manufacturers (2017-2022) &(USD/MT)
• Table 19. Global Imatinib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 20. Global Imatinib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Drugs as of 2021)
• Table 21. Imatinib Drugs Manufacturing Base Distribution and Headquarters
• Table 22. Manufacturers Imatinib Drugs Product Offered
• Table 23. Date of Manufacturers Enter into Imatinib Drugs Market
• Table 24. Mergers & Acquisitions, Expansion Plans
• Table 25. Global Imatinib Drugs Sales by Type (2017-2022) & (K MT)
• Table 26. Global Imatinib Drugs Sales by Type (2023-2028) & (K MT)
• Table 27. Global Imatinib Drugs Sales Share by Type (2017-2022)
• Table 28. Global Imatinib Drugs Sales Share by Type (2023-2028)
• Table 29. Global Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 30. Global Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 31. Global Imatinib Drugs Revenue Share by Type (2017-2022)
• Table 32. Global Imatinib Drugs Revenue Share by Type (2023-2028)
• Table 33. Imatinib Drugs Price by Type (2017-2022) & (USD/MT)
• Table 34. Global Imatinib Drugs Price Forecast by Type (2023-2028) & (USD/MT)
• Table 35. Global Imatinib Drugs Sales by Application (2017-2022) & (K MT)
• Table 36. Global Imatinib Drugs Sales by Application (2023-2028) & (K MT)
• Table 37. Global Imatinib Drugs Sales Share by Application (2017-2022)
• Table 38. Global Imatinib Drugs Sales Share by Application (2023-2028)
• Table 39. Global Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 40. Global Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 41. Global Imatinib Drugs Revenue Share by Application (2017-2022)
• Table 42. Global Imatinib Drugs Revenue Share by Application (2023-2028)
• Table 43. Imatinib Drugs Price by Application (2017-2022) & (USD/MT)
• Table 44. Global Imatinib Drugs Price Forecast by Application (2023-2028) & (USD/MT)
• Table 45. North America Imatinib Drugs Sales by Type (2017-2022) & (K MT)
• Table 46. North America Imatinib Drugs Sales by Type (2023-2028) & (K MT)
• Table 47. North America Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 48. North America Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 49. North America Imatinib Drugs Sales by Application (2017-2022) & (K MT)
• Table 50. North America Imatinib Drugs Sales by Application (2023-2028) & (K MT)
• Table 51. North America Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 52. North America Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 53. North America Imatinib Drugs Sales by Country (2017-2022) & (K MT)
• Table 54. North America Imatinib Drugs Sales by Country (2023-2028) & (K MT)
• Table 55. North America Imatinib Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 56. North America Imatinib Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 57. Europe Imatinib Drugs Sales by Type (2017-2022) & (K MT)
• Table 58. Europe Imatinib Drugs Sales by Type (2023-2028) & (K MT)
• Table 59. Europe Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 60. Europe Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 61. Europe Imatinib Drugs Sales by Application (2017-2022) & (K MT)
• Table 62. Europe Imatinib Drugs Sales by Application (2023-2028) & (K MT)
• Table 63. Europe Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 64. Europe Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 65. Europe Imatinib Drugs Sales by Country (2017-2022) & (K MT)
• Table 66. Europe Imatinib Drugs Sales by Country (2023-2028) & (K MT)
• Table 67. Europe Imatinib Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 68. Europe Imatinib Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 69. Asia Pacific Imatinib Drugs Sales by Type (2017-2022) & (K MT)
• Table 70. Asia Pacific Imatinib Drugs Sales by Type (2023-2028) & (K MT)
• Table 71. Asia Pacific Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 72. Asia Pacific Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 73. Asia Pacific Imatinib Drugs Sales by Application (2017-2022) & (K MT)
• Table 74. Asia Pacific Imatinib Drugs Sales by Application (2023-2028) & (K MT)
• Table 75. Asia Pacific Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 76. Asia Pacific Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 77. Asia Pacific Imatinib Drugs Sales by Region (2017-2022) & (K MT)
• Table 78. Asia Pacific Imatinib Drugs Sales by Region (2023-2028) & (K MT)
• Table 79. Asia Pacific Imatinib Drugs Revenue by Region (2017-2022) & (US$ Million)
• Table 80. Asia Pacific Imatinib Drugs Revenue by Region (2023-2028) & (US$ Million)
• Table 81. Latin America Imatinib Drugs Sales by Type (2017-2022) & (K MT)
• Table 82. Latin America Imatinib Drugs Sales by Type (2023-2028) & (K MT)
• Table 83. Latin America Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 84. Latin America Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 85. Latin America Imatinib Drugs Sales by Application (2017-2022) & (K MT)
• Table 86. Latin America Imatinib Drugs Sales by Application (2023-2028) & (K MT)
• Table 87. Latin America Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 88. Latin America Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 89. Latin America Imatinib Drugs Sales by Country (2017-2022) & (K MT)
• Table 90. Latin America Imatinib Drugs Sales by Country (2023-2028) & (K MT)
• Table 91. Latin America Imatinib Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 92. Latin America Imatinib Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 93. Middle East and Africa Imatinib Drugs Sales by Type (2017-2022) & (K MT)
• Table 94. Middle East and Africa Imatinib Drugs Sales by Type (2023-2028) & (K MT)
• Table 95. Middle East and Africa Imatinib Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 96. Middle East and Africa Imatinib Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 97. Middle East and Africa Imatinib Drugs Sales by Application (2017-2022) & (K MT)
• Table 98. Middle East and Africa Imatinib Drugs Sales by Application (2023-2028) & (K MT)
• Table 99. Middle East and Africa Imatinib Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 100. Middle East and Africa Imatinib Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 101. Middle East and Africa Imatinib Drugs Sales by Country (2017-2022) & (K MT)
• Table 102. Middle East and Africa Imatinib Drugs Sales by Country (2023-2028) & (K MT)
• Table 103. Middle East and Africa Imatinib Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 104. Middle East and Africa Imatinib Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 105. Apotex Inc. Corporation Information
• Table 106. Apotex Inc. Description and Major Businesses
• Table 107. Apotex Inc. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 108. Apotex Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 109. Apotex Inc. Recent Developments
• Table 110. Novartis Corporation Information
• Table 111. Novartis Description and Major Businesses
• Table 112. Novartis Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 113. Novartis Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 114. Novartis Recent Developments
• Table 115. Sanofi S.A. Corporation Information
• Table 116. Sanofi S.A. Description and Major Businesses
• Table 117. Sanofi S.A. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 118. Sanofi S.A. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 119. Sanofi S.A. Recent Developments
• Table 120. Cipla Inc. Corporation Information
• Table 121. Cipla Inc. Description and Major Businesses
• Table 122. Cipla Inc. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 123. Cipla Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 124. Cipla Inc. Recent Developments
• Table 125. Mylan Pharms Inc. Corporation Information
• Table 126. Mylan Pharms Inc. Description and Major Businesses
• Table 127. Mylan Pharms Inc. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 128. Mylan Pharms Inc. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 129. Mylan Pharms Inc. Recent Developments
• Table 130. Glenmark Pharmaceuticals Ltd. Corporation Information
• Table 131. Glenmark Pharmaceuticals Ltd. Description and Major Businesses
• Table 132. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 133. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 134. Glenmark Pharmaceuticals Ltd. Recent Developments
• Table 135. Sun Pharmaceuticals Corporation Information
• Table 136. Sun Pharmaceuticals Description and Major Businesses
• Table 137. Sun Pharmaceuticals Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 138. Sun Pharmaceuticals Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 139. Sun Pharmaceuticals Recent Developments
• Table 140. Actavis Generics Corporation Information
• Table 141. Actavis Generics Description and Major Businesses
• Table 142. Actavis Generics Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 143. Actavis Generics Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 144. Actavis Generics Recent Developments
• Table 145. Dr. Reddy's Laboratories Corporation Information
• Table 146. Dr. Reddy's Laboratories Description and Major Businesses
• Table 147. Dr. Reddy's Laboratories Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 148. Dr. Reddy's Laboratories Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 149. Dr. Reddy's Laboratories Recent Developments
• Table 150. Teva Pharmaceutical Industries Ltd. Corporation Information
• Table 151. Teva Pharmaceutical Industries Ltd. Description and Major Businesses
• Table 152. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
• Table 153. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 154. Teva Pharmaceutical Industries Ltd. Recent Developments
• Table 155. Key Raw Materials Lists
• Table 156. Raw Materials Key Suppliers Lists
• Table 157. Imatinib Drugs Distributors List
• Table 158. Imatinib Drugs Customers List
• Table 159. Imatinib Drugs Market Trends
• Table 160. Imatinib Drugs Market Drivers
• Table 161. Imatinib Drugs Market Challenges
• Table 162. Imatinib Drugs Market Restraints
• Table 163. Research Programs/Design for This Report
• Table 164. Key Data Information from Secondary Sources
• Table 165. Key Data Information from Primary Sources

List of Figures

• Figure 1. Imatinib Drugs Product Picture
• Figure 3. Global Imatinib Drugs Market Share by Type in 2021 & 2028
• Figure 3. Capsules Product Picture
• Figure 4. Tablets Product Picture
• Figure 5. Global Imatinib Drugs Market Share by Application in 2021 & 2028
• Figure 6. Hospitals
• Figure 7. Drug Stores
• Figure 8. Others
• Figure 9. Imatinib Drugs Report Years Considered
• Figure 10. Global Imatinib Drugs Sales 2017-2028 (K MT)
• Figure 11. Global Imatinib Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 12. Global Imatinib Drugs Revenue 2017-2028 (US$ Million)
• Figure 13. Global Imatinib Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 14. Global Imatinib Drugs Sales Market Share by Region (2017-2022)
• Figure 15. Global Imatinib Drugs Sales Market Share by Region (2023-2028)
• Figure 16. North America Imatinib Drugs Sales YoY (2017-2028) & (K MT)
• Figure 17. North America Imatinib Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 18. Europe Imatinib Drugs Sales YoY (2017-2028) & (K MT)
• Figure 19. Europe Imatinib Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 20. Asia-Pacific Imatinib Drugs Sales YoY (2017-2028) & (K MT)
• Figure 21. Asia-Pacific Imatinib Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 22. Latin America Imatinib Drugs Sales YoY (2017-2028) & (K MT)
• Figure 23. Latin America Imatinib Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 24. Middle East & Africa Imatinib Drugs Sales YoY (2017-2028) & (K MT)
• Figure 25. Middle East & Africa Imatinib Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 26. The Imatinib Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 27. The Top 5 and 10 Largest Manufacturers of Imatinib Drugs in the World: Market Share by Imatinib Drugs Revenue in 2021
• Figure 28. Global Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 29. Global Imatinib Drugs Sales Market Share by Type (2017-2028)
• Figure 30. Global Imatinib Drugs Revenue Market Share by Type (2017-2028)
• Figure 31. Global Imatinib Drugs Sales Market Share by Application (2017-2028)
• Figure 32. Global Imatinib Drugs Revenue Market Share by Application (2017-2028)
• Figure 33. North America Imatinib Drugs Sales Market Share by Type (2017-2028)
• Figure 34. North America Imatinib Drugs Revenue Market Share by Type (2017-2028)
• Figure 35. North America Imatinib Drugs Sales Market Share by Application (2017-2028)
• Figure 36. North America Imatinib Drugs Revenue Market Share by Application (2017-2028)
• Figure 37. North America Imatinib Drugs Sales Share by Country (2017-2028)
• Figure 38. North America Imatinib Drugs Revenue Share by Country (2017-2028)
• Figure 39. U.S. Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 40. Canada Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 41. Europe Imatinib Drugs Sales Market Share by Type (2017-2028)
• Figure 42. Europe Imatinib Drugs Revenue Market Share by Type (2017-2028)
• Figure 43. Europe Imatinib Drugs Sales Market Share by Application (2017-2028)
• Figure 44. Europe Imatinib Drugs Revenue Market Share by Application (2017-2028)
• Figure 45. Europe Imatinib Drugs Sales Share by Country (2017-2028)
• Figure 46. Europe Imatinib Drugs Revenue Share by Country (2017-2028)
• Figure 47. Germany Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 48. France Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 49. U.K. Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 50. Italy Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 51. Russia Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 52. Asia Pacific Imatinib Drugs Sales Market Share by Type (2017-2028)
• Figure 53. Asia Pacific Imatinib Drugs Revenue Market Share by Type (2017-2028)
• Figure 54. Asia Pacific Imatinib Drugs Sales Market Share by Application (2017-2028)
• Figure 55. Asia Pacific Imatinib Drugs Revenue Market Share by Application (2017-2028)
• Figure 56. Asia Pacific Imatinib Drugs Sales Share by Region (2017-2028)
• Figure 57. Asia Pacific Imatinib Drugs Revenue Share by Region (2017-2028)
• Figure 58. China Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 59. Japan Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 60. South Korea Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 61. India Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 62. Australia Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 63. Taiwan Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 64. Indonesia Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 65. Thailand Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 66. Malaysia Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 67. Philippines Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 68. Latin America Imatinib Drugs Sales Market Share by Type (2017-2028)
• Figure 69. Latin America Imatinib Drugs Revenue Market Share by Type (2017-2028)
• Figure 70. Latin America Imatinib Drugs Sales Market Share by Application (2017-2028)
• Figure 71. Latin America Imatinib Drugs Revenue Market Share by Application (2017-2028)
• Figure 72. Latin America Imatinib Drugs Sales Share by Country (2017-2028)
• Figure 73. Latin America Imatinib Drugs Revenue Share by Country (2017-2028)
• Figure 74. Mexico Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 75. Brazil Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 76. Argentina Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 77. Middle East and Africa Imatinib Drugs Sales Market Share by Type (2017-2028)
• Figure 78. Middle East and Africa Imatinib Drugs Revenue Market Share by Type (2017-2028)
• Figure 79. Middle East and Africa Imatinib Drugs Sales Market Share by Application (2017-2028)
• Figure 80. Middle East and Africa Imatinib Drugs Revenue Market Share by Application (2017-2028)
• Figure 81. Middle East and Africa Imatinib Drugs Sales Share by Country (2017-2028)
• Figure 82. Middle East and Africa Imatinib Drugs Revenue Share by Country (2017-2028)
• Figure 83. Turkey Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 84. Saudi Arabia Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 85. UAE Imatinib Drugs Revenue (2017-2028) & (US$ Million)
• Figure 86. Imatinib Drugs Value Chain
• Figure 87. Imatinib Drugs Production Process
• Figure 88. Channels of Distribution
• Figure 89. Distributors Profiles
• Figure 90. Bottom-up and Top-down Approaches for This Report
• Figure 91. Data Triangulation
• Figure 92. Key Executives Interviewed